A £175m deal has been agreed for a Cheshire-headquartered veterinary pharmaceuticals business to buy a counterpart in the US.
Dechra Pharmaceuticals is set to acquire Piedmont Animal Health which specialises in developing products for pets.
The Northwich company has also announced plans to conduct a non-pre-emptive placing to raise approximately £180m by issuing more than 5.2 million new ordinary shares which represent about 4.8% of its existing issued share capital.
